Clinical Trials Sponsored by Ascopharm Groupe Novasco

Total 9 results

Ascopharm Groupe Novasco

Completed

Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer (PA0903)

Root Canal Obturation

France, United Kingdom
Pharnext SA
Ascopharm Groupe Novasco

Completed

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) (PLEODIAL-I)

Alzheimer Disease

France
Pharnext SA
Ascopharm Groupe Novasco

Completed

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion (PLEODIAL-II)

Alzheimer Disease

France
Ascopharm Groupe Novasco
Ramsay Générale de Santé

Unknown

ACL Versus ALL + ACL Study

Anterior Cruciate Ligament Injury | Ligament Rupture

France
Ascopharm Groupe Novasco
AscoPharm is conducting the study under the responsibility of SEPTODONT

Completed

Efficacy and the Safety Study of RD94 in Patients With Endodontic Care (RD94)

Tooth Injury

France
Ascopharm Groupe Novasco
Groupe Hospitalier Pitie-Salpetriere; Medco Health Solutions, Inc.

Completed

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction. (DOSAPI)

Anti Platelet Effects

France
AI Labs Group S.L
Osakidetza; Hospital Universitario Cruces; Servicio Vasco de Salud Osakidetza...

Recruiting

Pilot Study: AI Algorithm for Dermatology Referral Optimization (DAO_DERIVATION)

Skin Diseases | Skin Condition

Spain
AI Labs Group S.L
Hospital de Basurto; Osakidetza; Hospital de Cruces; Servicio Vasco de Salud Osakidetza...

Recruiting

Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma (LEGIT_MC_EVCDA)

Melanoma | Melanoma, Skin

Spain
Wuerzburg University Hospital
Klinikum Ludwigsburg; University Hospital Ulm; Ovesco Endoscopy AG; Waid City Hospital... and other collaborators

Withdrawn

Impact of Hybrid-ESD+ and LiftUp® on the en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm (HADRIAN)

Colorectal Adenoma

Germany, Switzerland

Clinical Trials Sponsored by Ascopharm Groupe Novasco

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations